TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice

Area of Science:

• Hepatology
• Molecular Biology
• Metabolic Disorders

Background:

• Nonalcoholic fatty liver disease (NAFLD) is prevalent with no effective treatments.
• The precise mechanisms driving NAFLD pathogenesis require further elucidation.

Purpose of the Study:

• To investigate the role of TRUSS (tumor necrosis factor receptor-associated ubiquitous scaffolding and signaling protein) in NAFLD and metabolic disorders.
• To elucidate the molecular mechanisms by which TRUSS influences NAFLD.

Main Methods:

• Analysis of TRUSS expression in human NAFLD liver specimens and mouse models.
• Conditional knockout and overexpression of TRUSS in hepatocytes of mice fed high-fat diets or spontaneously obese mice.
• Investigation of TRUSS interaction with IκBα (inhibitor of nuclear factor κB α) and its effect on NF-κB (nuclear factor κB) activation.

Main Results:

• TRUSS expression is elevated in NAFLD and obesity models.
• Hepatocyte-specific TRUSS knockout ameliorates NAFLD, insulin resistance, and inflammation.
• TRUSS promotes NAFLD and metabolic dysfunction by enhancing IκBα ubiquitination and degradation, leading to NF-κB activation.

Conclusions:

• Hepatocyte TRUSS acts as a positive regulator in NAFLD and metabolic disorders.
• TRUSS-mediated NF-κB activation is a key mechanism driving these conditions.
• Targeting TRUSS presents a potential therapeutic strategy for NAFLD prevention and treatment.